The Evolving Role of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Bladder Cancer

Gain expert insight on the optimal use of immune checkpoint inhibitors for bladder cancer with this interactive video module, downloadable slideset, and quick reference pocket guide!
David Y. T. Chen
David Y. T. Chen, MD, FACS
Alexander Kutikov, MD, FACS
Elizabeth R. Plimack, MD, MS

Video Module

This 3-part video series provides expert insights and practical guidance on the multidisciplinary approach to immunotherapy for the treatment of patients with urothelial cancer for urologists and medical oncologists.

David Y. T. Chen David Y. T. Chen, MD, FACS Alexander Kutikov, MD, FACS Elizabeth R. Plimack, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 22, 2018 Expired: No longer available for credit

Downloadable Slideset

Download slides with key data on the optimal use of immune checkpoint inhibitors for bladder cancer and strategies for multidisciplinary care to optimize patient outcomes.

David Y. T. Chen David Y. T. Chen, MD, FACS Alexander Kutikov, MD, FACS Elizabeth R. Plimack, MD, MS Released: August 22, 2018

PDF Resource

This downloadable resource accompanies the training video and highlights expert insights and practical guidance on the multidisciplinary approach to immunotherapy for the treatment of patients with urothelial cancer for urologists and medical oncologists.

David Y. T. Chen David Y. T. Chen, MD, FACS Alexander Kutikov, MD, FACS Elizabeth R. Plimack, MD, MS Released: August 28, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

This activity is supported by an educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue